|
期刊名称：JOURNAL OF PERSONALIZED MEDICINE
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Journal of Personalized Medicine (ISSN 2075-4426; CODEN: JPMOB3) is an international peer-reviewed open access journal on personalized medicine published quarterly online by MDPI.
- Open Access—free for readers, with article processing charges (APC) paid by authors or their institutions.
- High Visibility: Covered by the Science Citation Index Expanded (SCIE - Web of Science). Citations available in PubMed; full-text archived in PubMed Central. Indexed in Scopus.
- CiteScore 2018 (Scopus): 3.59, which equals rank 41/206 (Q1) in 'Medicine (miscellaneous).'
- Rapid Publication: manuscripts are peer-reviewed and a first decision provided to authors approximately 19 days after submission; acceptance to publication is undertaken in 4.1 days (median values for papers published in this journal in the first half of 2020).
- Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.
-
Aims
Journal of Personalized Medicine (JPM; ISSN 2075-4426) is an international, open access journal aimed at bringing all aspects of personalized medicine to one platform. JPM publishes cutting edge, innovative preclinical and translational scientific research and technologies related to personalized medicine (e.g., precision medicine, pharmacogenomics/proteomics, systems biology, ‘omics association analysis).
For a comprehensive perspective of primary research, commentaries, and reviews related to personalized medicine, also termed precision medicine, JPM aims to integrate expertise from the molecular and translational sciences, therapeutics and diagnostics, as well as discussions of regulatory, social, ethical and policy aspects. We provide a forum to bring together academic and clinical researchers, biotechnology, diagnostic and pharmaceutical companies, health professionals, regulatory and ethical experts, and government and regulatory authorities.
Scope
Topics of interest with a view towards personalized medicine include (but are not limited to) the following:
- Omics-based studies of disease risk, disease prognosis, and response to therapy
- Biomarker identification and application
- Drug target discovery and integration with individualized therapy
- Pharmacogenomics – genetics and biochemistry of drug uptake, action, and metabolism
- Prediction-based drug safety
- Novel therapeutics: genetic-based, nanotechnology, targeting strategies
- Advancements in Technologies and Resources
- Genetic testing, sequencing technologies, and molecular diagnostics
- Expression analysis, metabolomics, proteomics
- Microbiomes
- Genome-wide association studies
- Bioinformatics and health informatics
- Biostatistics
- Personalization of omics-based non-drug related health interventions
- Regulation and bioethics in personalized medicine
-
Indexing & Abstracting Services
Full-text Archives
Content Aggregators
Instructions to Authors
Editorial Board
https://www.mdpi.com/journal/jpm/editors
|
|
|
|
